Mammographic density and survival in interval breast cancers

Breast Cancer Research

Volumn 15, Issue 3, 2013, Pages

  Eriksson, Louise ^a   Czene, Kamila ^a   Rosenberg, Lena U ^b   Törnberg, Sven ^c   Humphreys, Keith ^a   Hall, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER PROGNOSIS; CANCER SCREENING; CANCER SPECIFIC SURVIVAL; CASE CONTROL STUDY; FEMALE; HUMAN; INTERVAL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; ONCOLOGICAL PARAMETERS; POSTMENOPAUSE; STATISTICAL SIGNIFICANCE; SWEDEN; TUMOR VOLUME; BREAST NEOPLASMS; EARLY DIAGNOSIS; MAMMARY GLAND; MIDDLE AGED; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RADIOGRAPHY; RISK FACTOR; SURVIVAL;

ADULT; AGED; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL; SWEDEN;

EID: 84879082724     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3440     Document Type: Article

References (35)

1. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-1169. 10.1158/1055-9965.EPI-06-0034, 16775176.
2. Porter PL, El-Bastawissi AY, Mandelson MT, Lin MG, Khalid N, Watney EA, Cousens L, White D, Taplin S, White E. Breast tumor characteristics as predictors of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 1999, 91:2020-2028. 10.1093/jnci/91.23.2020, 10580027.
3. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996, 276:33-38. 10.1001/jama.1996.03540010035027, 8667536.
4. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007, 356:227-236. 10.1056/NEJMoa062790, 17229950.
5. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 2003, 5:R129-135. 10.1186/bcr622, 314426, 12927043.
6. Fisher ER, Palekar A, Kim WS, Redmond C. The histopathology of mammographic patterns. Am J Clin Pathol 1978, 69:421-426.
7. Ghosh K, Brandt KR, Reynolds C, Scott CG, Pankratz VS, Riehle DL, Lingle WL, Odogwu T, Radisky DC, Visscher DW, Ingle JN, Hartmann LC, Vachon CM. Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat 2012, 131:267-275. 10.1007/s10549-011-1727-4, 3707294, 21877142.
8. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 2001, 10:243-248.
9. Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:343-349. 10.1158/1055-9965.EPI-04-0490, 15734956.
10. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Chen H, Hallett M, Park M. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 2008, 14:518-527. 10.1038/nm1764, 18438415.
11. Aiello EJ, Buist DS, White E, Porter PL. Association between mammographic breast density and breast cancer tumor characteristics. Cancer Epidemiol Biomarkers Prev 2005, 14:662-668. 10.1158/1055-9965.EPI-04-0327, 15767347.
12. Sala E, Solomon L, Warren R, McCann J, Duffy S, Luben R, Day N. Size, node status and grade of breast tumours: association with mammographic parenchymal patterns. Eur Radiol 2000, 10:157-161. 10.1007/s003300050025, 10663736.
13. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 2011, 103:1179-1189. 10.1093/jnci/djr225, 3149043, 21795664.
14. Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P. The influence of mammographic density on breast tumor characteristics. Breast Cancer Res Treat 2012, 134:859-866. 10.1007/s10549-012-2127-0, 22710708.
15. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 2011, 13:223. 10.1186/bcr2942, 3326547, 22114898.
16. Heusinger K, Jud SM, Häberle L, Hack CC, Adamietz BR, Meier-Meitinger M, Lux MP, Wittenberg T, Wagner F, Loehberg CR, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Fasching PA. Association of mammographic density with hormone receptors in invasive breast cancers: results from a case-only study. Int J Cancer 2012, 131:2643-2649. 10.1002/ijc.27515, 22392346.
17. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara ES, Li CI. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol 2012, 22:340-348. 3338877, 22366170.
18. Antoni S, Sasco AJ, dos Santos Silva I, McCormack V. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat 2013, 137:337-347. 10.1007/s10549-012-2362-4, 23239150.
19. Pollán M, Ascunce N, Ederra M, Murillo A, Erdozáin N, Alés-Martínez JE, Pastor-Barriuso R. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res 2013, 15:R9. 10.1186/bcr3380, 3672793, 23360535.
20. Frisell J, von Rosen A, Wiege M, Nilsson B, Goldman S. Interval cancer and survival in a randomized breast cancer screening trial in Stockholm. Breast Cancer Res Treat 1992, 24:11-16. 10.1007/BF01832353, 1463867.
21. Magnusson C, Baron JA, Correia N, Bergström R, Adami HO, Persson I. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 1999, 81:339-344. 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6, 10209946.
22. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000, 60:3744-3748.
23. Tamimi RM, Hankinson SE, Colditz GA, Byrne C. Endogenous sex hormone levels and mammographic density among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2005, 14:2641-2647. 10.1158/1055-9965.EPI-05-0558, 16284390.
24. Livshits G, Malkin I, Williams FM, Hart DJ, Hakim A, Spector TD. Longitudinal study of variation in body mass index in middle-aged UK females. Age (Dordr) 2012, 34:1285-1294. 10.1007/s11357-011-9299-0, 3448995,3448995, 21853263.
25. Rutter CM, Mandelson MT, Laya MB, Seger DJ, Taplin S. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. JAMA 2001, 285:171-176. 10.1001/jama.285.2.171, 11176809.
26. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410. 10.1111/j.1365-2559.1991.tb00229.x, 1757079.
27. Nyström L, Larsson LG, Rutqvist LE, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials: a comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995, 34:145-152. 10.3109/02841869509093948, 7718250.
28. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994, 39:1629-1638. 10.1088/0031-9155/39/10/008, 15551535.
29. American College of Radiology The ACR breast imaging reporting and data system. BI-RADS: Mammography 2003, 3-5. Reston, VA: American College of Radiology, 4, American College of Radiology.
30. Nicholson BT, LoRusso AP, Smolkin M, Bovbjerg VE, Petroni GR, Harvey JA. Accuracy of assigned BI-RADS breast density category definitions. Acad Radiol 2006, 13:1143-1149. 10.1016/j.acra.2006.06.005, 16935726.
31. Shen Y, Yang Y, Inoue LY, Munsell MF, Miller AB, Berry DA. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. J Natl Cancer Inst 2005, 97:1195-1203. 10.1093/jnci/dji239, 16106024.
32. Jatoi I, Hilsenbeck SG, Clark GM, Osborne CK. Significance of axillary lymph node metastasis in primary breast cancer. J Clin Oncol 1999, 17:2334-2340.
33. Törnberg S, Codd M, Rodrigues V, Segnan N, Ponti A. Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres. J Med Screen 2005, 12:43-49. 10.1258/0969141053279077, 15814019.
34. Mandelson MT, Oestreicher N, Porter PL, White D, Finder CA, Taplin SH, White E. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000, 92:1081-1087. 10.1093/jnci/92.13.1081, 10880551.
35. Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 2007, 9:217. 10.1186/bcr1829, 2246184, 18190724.